Complementary Medicine for Sides Effects of Anticancer Therapies
A special issue of Medicines (ISSN 2305-6320).
Deadline for manuscript submissions: closed (31 August 2020) | Viewed by 347
Special Issue Editor
Special Issue Information
Dear Colleagues:
The side effects of conventional anticancer therapy are a huge burden for many oncologic patients. The adverse effects of chemotherapy, radiation, and/or surgical therapy often prevent the regular performance of conventional therapy, thereby leading to a reduction of the previously suggested amount of chemo- and or radiation therapy—or even to their cancellation. Additive complementary medicine (CM) might be suggested to improve the situation of these patients. There is literature on the influence of CM on side effects. In addition, CM may have a place in the improvement of cancer patients’ quality of life (QoL). Knowledge of the interaction of conventional medicine and CM is mandatory for all physicians dealing with cancer patients. The use of CM requires specialized training in order to apply it correctly. A high number of cancer patients use CM. This Issue focuses on the use of CM aiming at the alleviation of the side effects of conventional medicine.
Prof. Dr. Michael Frass
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicines is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- complementary medicine
- anticancer therapy
- sides effects
- adverse effects
- chemotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
